<DOC>
	<DOC>NCT01510535</DOC>
	<brief_summary>The purpose of this study is to compare efficacy and safety of intra-articular LBSA0103 once versus intra-articular hyaluronic acid injections (Hyruan Plus Injection) once weekly for 3 weeks in the treatment of patients with osteoarthritis of the knee.</brief_summary>
	<brief_title>Efficacy and Safety of LBSA0103 Versus Hyruan Plus Injection in Patients With Knee Osteoarthritis</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis, Knee</mesh_term>
	<criteria>Over 40 years of age Kellgren &amp; Lawrence grade IIII If there is more than one knee having a weight bearing pain of at least 40mm evaluated by 100mm VAS Be willing to discontinue all nonsteroidal antiinflammatory drugs(NSAIDs), analgesics, condroichin sulfate/glucosamine or physical therapy for the duration of the study Body mass index &gt; 32 Have rheumarthritis Patients who have a weightbearing pain of less than 40mm on both knees when measured by 100mmVAS Have Sudek's atrophy, Paget's disease, Spinal disc herniation Kellgren &amp; Lawrence Grade IV</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Osteoartritis</keyword>
	<keyword>Knee</keyword>
	<keyword>LBSA0103</keyword>
	<keyword>Hyruan Plus Inj.</keyword>
</DOC>